Multiple tissue methylation analysis of HTR2A exon I in suicidal behavior

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Epigenetic alterations, specifically DNA methylation, are increasingly recognized as crucial in complex behaviors.
• The serotonin 2A receptor (HTR2A) gene is implicated in mood regulation and suicidal behavior.
• Tissue-specific epigenetic mechanisms may influence the manifestation of psychiatric conditions.

Purpose of the Study:

• To investigate epigenetic modifications in HTR2A exon I CpG sites as potential risk factors for suicidal behavior.
• To analyze these epigenetic changes in both saliva and post-mortem brain tissue.
• To determine if HTR2A methylation can improve the prediction of suicidal behavior.

Main Methods:

• Genomic DNA was extracted from saliva samples of schizophrenia patients (20 attempters, 27 non-attempters) and post-mortem brain tissue (9 suicide victims, 11 controls).
• Bisulfite pyrosequencing was employed to assess methylation levels at six CpG sites within HTR2A exon I, including the rs6313 (C102T) site.
• Correlation analysis was performed to compare methylation levels between tissues.

Main Results:

• No significant differences in HTR2A exon I CpG methylation were observed between suicide attempters and non-attempters (P=0.759).
• Similarly, no significant methylation differences were found between suicide victims and controls (P=0.189).
• A strong positive correlation (r=0.547, P<0.001) was found between CpG methylation levels in blood and saliva.

Conclusions:

• The study's findings do not support the hypothesis that HTR2A exon I methylation is a significant epigenetic factor in suicidal behavior.
• Methylation analysis of HTR2A does not appear to be a useful biomarker for predicting suicidal behavior.
• Despite high methylation in saliva (approx. 80%) and lower levels in the frontal cortex (approx. 30%), no link to suicidal behavior was established.